Technical and clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in patients with COVID-19.
COVID-19
ERCP
training
Journal
Therapeutic advances in gastroenterology
ISSN: 1756-283X
Titre abrégé: Therap Adv Gastroenterol
Pays: England
ID NLM: 101478893
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
09
2020
accepted:
20
11
2020
entrez:
11
1
2021
pubmed:
12
1
2021
medline:
12
1
2021
Statut:
epublish
Résumé
The unprecedented situation caused by the coronavirus disease 2019 (COVID-19) pandemic has profoundly affected endoscopic practice in regard to access, volume, and workflow. We aimed to assess the potential changes in the technical outcomes of endoscopic retrograde cholangiopancreatography (ERCP) procedures carried out in patients with confirmed SARS-CoV-2 infection. We conducted an international, multicenter, retrospective, matched case-control study of ERCP procedures carried out in patients with confirmed COVID-19. The main outcome was technical success of the procedure as assessed by the endoscopist, and the secondary outcome was the development of procedure-related adverse events. Each case was matched in a 1:4 ratio with controls extracted from each center's database in order to identify relevant changes in outcome measures compared with the pre-pandemic era. Eighteen procedures performed in 16 COVID-19 patients [14 men, 65 years (9-82)] and 67 controls were included in the final analysis. Technical success was achieved in 14/18 COVID-19 cases, which was significantly lower as compared with the control group (14/18 The COVID-19 pandemic has affected the volume and practice of ERCP, resulting in lower technical success rates without significantly impacting patient safety. Prioritizing cases and following recommendations on safety measures can ensure good outcome with minimal risk in dedicated centers.
Sections du résumé
BACKGROUND
BACKGROUND
The unprecedented situation caused by the coronavirus disease 2019 (COVID-19) pandemic has profoundly affected endoscopic practice in regard to access, volume, and workflow. We aimed to assess the potential changes in the technical outcomes of endoscopic retrograde cholangiopancreatography (ERCP) procedures carried out in patients with confirmed SARS-CoV-2 infection.
METHODS
METHODS
We conducted an international, multicenter, retrospective, matched case-control study of ERCP procedures carried out in patients with confirmed COVID-19. The main outcome was technical success of the procedure as assessed by the endoscopist, and the secondary outcome was the development of procedure-related adverse events. Each case was matched in a 1:4 ratio with controls extracted from each center's database in order to identify relevant changes in outcome measures compared with the pre-pandemic era.
RESULTS
RESULTS
Eighteen procedures performed in 16 COVID-19 patients [14 men, 65 years (9-82)] and 67 controls were included in the final analysis. Technical success was achieved in 14/18 COVID-19 cases, which was significantly lower as compared with the control group (14/18
CONCLUSIONS
CONCLUSIONS
The COVID-19 pandemic has affected the volume and practice of ERCP, resulting in lower technical success rates without significantly impacting patient safety. Prioritizing cases and following recommendations on safety measures can ensure good outcome with minimal risk in dedicated centers.
Identifiants
pubmed: 33425011
doi: 10.1177/1756284820980671
pii: 10.1177_1756284820980671
pmc: PMC7756189
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1756284820980671Informations de copyright
© The Author(s), 2020.
Déclaration de conflit d'intérêts
Conflict of interest statement: Michiel Bronswijk received travel grants from Taewoong, Takeda, and Prion Medical. Schalk van der Merwe holds the Cook chair in interventional endoscopy and holds consultancy agreements with Cook, Pentax and Olympus. Professor Guido Costamagna is a consultant for Cook Medical, Boston Scientific, and Olympus. Ivo Boškoski is a consultant for Apollo Endosurgery, Cook Medical, and Boston Scientific; board member for Endo Tools; research grant recipient from Apollo Endosurgery. Also, he has received food and beverage compensation from Apollo Endosurgery, Cook Medical, Boston Scientific, and Endo Tools. The other authors report no conflict of interest.
Références
Dig Liver Dis. 2020 Aug;52(8):819-822
pubmed: 32593516
Gastrointest Endosc. 2000 May;51(5):535-9
pubmed: 10805837
Therap Adv Gastroenterol. 2020 Jun 24;13:1756284820935187
pubmed: 32636930
Endoscopy. 2020 Jun;52(6):483-490
pubmed: 32303090
Gastrointest Endosc. 2010 Mar;71(3):446-54
pubmed: 20189503
Gastrointest Endosc. 2020 Oct;92(4):925-935
pubmed: 32535193
Gastroenterology. 2020 May;158(6):1518-1519
pubmed: 32142785
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Rom J Intern Med. 2018 Mar 1;56(1):55-61
pubmed: 29080394
Am J Emerg Med. 2020 Jun 18;:
pubmed: 32611498
Anaesthesia. 2020 Aug;75(8):1086-1095
pubmed: 32311771
Endoscopy. 2018 Nov;50(11):1116-1127
pubmed: 30340220
Gastrointest Endosc. 2020 Aug;92(2):448-454
pubmed: 32305345
Endoscopy. 2020 Oct;52(10):891-898
pubmed: 32643767
Scand J Gastroenterol. 2020 Jul;55(7):870-876
pubmed: 32615891
Endoscopy. 2020 Dec;52(12):1111-1115
pubmed: 32557489
Endoscopy. 2020 Feb;52(2):127-149
pubmed: 31863440
Eur J Gastroenterol Hepatol. 2020 Oct;32(10):1301-1304
pubmed: 32773511
Gastrointest Endosc. 2012 Jul;76(1):18-24
pubmed: 22579258
Dig Liver Dis. 2020 Dec;52(12):1396-1402
pubmed: 32507619
Endoscopy. 2020 Feb;52(2):115-122
pubmed: 31766060